Navigation Links
Jonathan Finder, M.D., Joins Point Pleasant Pediatric Special Care's Medical Management Team as Pulmonary Consultant
Date:3/23/2009

ALIQUIPPA, Pa., March 23 /PRNewswire/ -- Dr. Jonathan Finder of Children's Hospital of Pittsburgh of UPMC will provide pulmonary consulting services for Point Pleasant pediatric special care located in Aliquippa (Hopewell township), Pa. The 70 bed pediatric community opened in February 2008 and is licensed to provide long term and transitional care for medically fragile children. It is the only community in western Pennsylvania specifically designed to provide long-term care for ventilator-dependent children and young adults

Dr. Finder is a board certified Pediatric Pulmonologist who graduated from Yale University and Albany Medical College. He completed his internship, residency, and fellowship from Massachusetts General Hospital. Joe Coyle, President of Point Pleasant Management Company, states, "Dr. Finder is a nationally recognized and well-published Pediatric Pulmonologist, who will be an outstanding addition to our Medical Management Team in Pittsburgh." Dr. Finder will collaborate with the facility's Medical Director, Dr. Jacqueline Saladino, of Sewickley Valley Pediatrics.

Point Pleasant pediatric special care, has headquarters in Radnor, Pa, and also operates three Point Pleasant pediatric care communities in Bucks County, Pennsylvania, and one in Lancaster Pa. A Philadelphia location is scheduled to open in late 2009. 

    Clinical and Admission Information:
    Contact Jenn White, M.S.W.
    866-498-3998
    E-Mail: jwhite@pointpleasantcare.com

Web Site: http://www.pointpleasantcare.com


'/>"/>
SOURCE Point Pleasant Pediatric Special Care
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Dr. Jonathan White Joins Haemonetics as Head of Research and Development
2. Emmy Winner Jonathan Jackson With Rock Band Enation Take On Predators & Rapists
3. Jonathan Jacobson Appointed General Manager, Global Business Strategies & Operations, Menicon Co., Ltd.
4. Jailed Indian Pediatrician Wins 2008 Jonathan Mann Award for Global Health and Human Rights
5. Kimberly Finder, M.D. Asks: Are We Really In an Economic Recession?
6. ULURU Inc. Announces Appointment of Jeffrey A. Niezgoda, M.D., as Chairman of Scientific Advisory Board
7. The Columbia University Department of Obstetrics and Gynecology is Happy to Announce That Charles S. Kleinman, M.D., Will Begin Seeing Patients at Columbia Eastside
8. CorNova Announces Addition of Andrew T. Jay, D.M.D., M.B.A., to its Board of Directors
9. Joseph D. Zuckerman, M.D., Elected President of the American Academy of Orthopaedic Surgeons
10. Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO
11. 2009 DeLee Humanitarian Award goes to Marshall Lindheimer, M.D., of the University of Chicago
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Drinking Your Way to Health 3F Perhaps Not 59700 1Drinking Your Way to Health 3F Perhaps Not 59700 2Drinking Your Way to Health 3F Perhaps Not 59700 3UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 1UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 2UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 3UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 4UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 5UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 6UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 7UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 8UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 9UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 10UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 11UCBs Cimzia 28R 29 28certolizumab pegol 29 Shows Rapid and Sustained Clinical Response in Adult Patients Living with Moderate to Severe Rheumatoid A 14516 12Video Games Can Play Havoc With Kids Joints 59696 1Video Games Can Play Havoc With Kids Joints 59696 2Video Games Can Play Havoc With Kids Joints 59696 3